Cargando…
Combotherapy and current concepts as well as future strategies for the treatment of Alzheimer’s disease
It has been estimated that 35.6 million people globally had dementia in 2010 and the prevalence of dementia has been predicted to double every 20 years. Thus, 115.4 million people may be living with dementia in 2050. Alzheimer’s disease (AD) is the leading cause of dementia and is present in 60%–70%...
Autores principales: | Fan, Ling-Yun, Chiu, Ming-Jang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956689/ https://www.ncbi.nlm.nih.gov/pubmed/24648738 http://dx.doi.org/10.2147/NDT.S45143 |
Ejemplares similares
-
Anti‐VEGF‐A/ANG2 combotherapy limits pathological angiogenesis in the eye: a replication study
por: Wolf, Anne, et al.
Publicado: (2019) -
Impact of Bone Metastases on Patients with Renal Cell Carcinoma or Melanoma Treated with Combotherapy Ipilimumab Plus Nivolumab
por: Pham, Félix, et al.
Publicado: (2022) -
Alzheimer’s disease and epilepsy: shared neuropathology guides current and future treatment strategies
por: Lu, Olivia, et al.
Publicado: (2023) -
Current and Future Treatments in Alzheimer Disease: An Update
por: Yiannopoulou, Konstantina G, et al.
Publicado: (2020) -
Current and Near-Future Treatment of Alzheimer’s Disease
por: Gąsiorowski, Kazimierz, et al.
Publicado: (2022)